The information was submitted for publication, through the agency of the contact person set out above, at 7.20 pm CET on December 8, 2021. To access the presentation through webcast, please use this link: Īlternatively, use the following link to download the presentation:Ī recorded version can be accessed for 3 years via Īnna Appelqvist, VP Corporate CommunicationsĮmail: information is information that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation. Please see dial in details below to join the conference:ĭuring the conference call a presentation will be held. The provision will be reported as an item affecting comparability and it will impact the operating result for Q4 2021.Ī conference call will be held on December 8, 2021, at 7:45-8:15 pm CET hosted by Mattias Perjos, President & CEO, and Lars Sandström, CFO. The settlement amount will be funded through available funds. Getinge made a provision of SEK 1.8 Bn in 2018 for expected costs associated with surgical mesh claims, based on information available at the time. The surgical mesh implants were manufactured by Getinge's subsidiary Atrium Medical Corporation, which was acquired by Getinge in 2011.

The litigation against the insurers will also continue. Costs for such litigations are not expected to be material. Getinge will continue to defend against any litigation that the final agreement does not resolve. The settlement is not an admission of liability or wrongdoing by the company. Getinge expects the settlement to become final and payment to be made during the first half of 2022. There are currently about 3,200 plaintiffs in the MDL and the settlement aims to maximize the participation rate by the vast majority of claims filed up until November 30, 2021. The settlement is subject to certain contingencies, including participation by a certain high level of plaintiffs in the MDL. The settlement agreement was today executed to resolve matters pending in the District Court of New Hampshire, US. 'I am pleased that we can put this behind us and fully focus on our core business, and delivering on our strategy', says Mattias Perjos, President & CEO Getinge. An additional provision of SEK 600 M is made to account for the settlement in addition to litigation expenses incurred to date. 9, 2021 /PRNewswire/ - Getinge's subsidiary Atrium Medical Corporation has entered into a settlement agreement with plaintiffs' lead counsel related to the multidistrict litigation (MDL) linked to surgical mesh product liability in the US.

Mesh enabler free